What is the current annual cash & cash equivalents of NVO?

As of today, NVO annual cash & cash equivalents is $4.24B

What is 1-year change in NVO annual cash & cash equivalents?

NVO annual cash & cash equivalents is up +16.05% year-over-year

What is 3-year change in NVO annual cash & cash equivalents?

NVO annual cash & cash equivalents is up +25.31% over the past 3 years

How far is NVO annual cash & cash equivalents from its all-time high?

NVO annual cash & cash equivalents is currently -5.36% below its historical high of $4.48B set on December 31, 2023

How does NVO annual cash & cash equivalents rank versus sector peers?

NVO annual cash & cash equivalents is higher than 97.00% of companies in Healthcare sector

When is NVO next annual earnings release?

As of today, the next annual earnings release for NVO has not been scheduled

What is the current quarterly cash & cash equivalents of NVO?

As of today, NVO quarterly cash & cash equivalents is $6.88B

What is NVO quarterly cash & cash equivalents most recent change?

NVO quarterly cash & cash equivalents was up +106.33% on June 30, 2026

What is 1-year change in NVO quarterly cash & cash equivalents?

NVO quarterly cash & cash equivalents is up +130.95% year-over-year

How far is NVO quarterly cash & cash equivalents from its all-time high?

NVO quarterly cash & cash equivalents is currently -38.63% below its historical high of $11.21B set on September 30, 2024

How does NVO quarterly cash & cash equivalents rank versus sector peers?

NVO quarterly cash & cash equivalents is higher than 98.49% of companies in Healthcare sector

When is NVO next earnings release?

The next earnings release for NVO is on November 4, 2026

NVO Cash & Equivalents History & Chart Since 1980

Annual Cash & Cash Equivalents

$4.24B$586.50M+16.05%

December 31, 2025

Summary

Current Value: As of today, NVO annual cash & cash equivalents is $4.24B, up +16.05% on December 31, 2025
Historical Performance: NVO annual cash & cash equivalents is up +25.31% over the past 3 years, up +102.17% over the past 5 years
All-Time High Comparison: NVO annual cash & cash equivalents is currently -5.36% below its historical high of $4.48B set on December 31, 2023
3-Year Low Comparison: NVO annual cash & cash equivalents is +25.31% above its 3-year low of $3.38B reached on an earlier date
Sector Comparison: NVO annual cash & cash equivalents is higher than 97.00% of companies in Healthcare sector

Cash and Cash Equivalents Chart

beforeafter

SUGGESTED SERIES

Performance

NVO Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual Cash & Cash Equivalents	Dec 31, 25	$4.24B	+16.1%	+25.3%	+102.2%	+46.7%
Quarterly Cash & Cash Equivalents	Jun 30, 26	$6.88B	+130.9%	+29.0%	+58.5%	+114.6%
Price	Aug 19, 26	$46.68	-14.8%	-49.0%	-11.6%	+339.3%
Annual Current Assets	Dec 31, 25	$27.12B	+21.4%	+74.6%	+150.7%	+303.9%
Annual Total Liabilities	Dec 31, 25	$54.85B	+22.6%	+142.3%	+309.0%	+1146.9%
Annual Working Capital	Dec 31, 25	-$6.79B	+13.6%	-271.4%	-825.9%	-300.6%
Annual Net Income	Dec 31, 25	$15.49B	+5.8%	+97.5%	+140.4%	+505.3%

Cash and Cash Equivalents Highs

NVO Annual Cash & Cash Equivalents Highs Comparison
Period	High	Date	Current
3Y	$4.48B	Dec 31, 23	-5.4%
5Y	$4.48B	Dec 31, 23	-5.4%
All	$4.48B	Dec 31, 23	-5.4%

Cash and Cash Equivalents Lows

NVO Annual Cash & Cash Equivalents Lows Comparison
Period	Low	Date	Current
3Y	$3.38B	N/A	+25.3%
5Y	$2.10B	N/A	+102.2%
All	$42.25M	Dec 1, 80	+9935.5%

Cash and Cash Equivalents History

Year	Value	Change
2025	$4.24B	+16.1%
2024	$3.65B	-18.5%
2023	$4.48B	+32.4%
2022	$3.38B	+26.6%
2021	$2.67B	+27.5%
2020	$2.10B	-9.8%
2019	$2.32B	-3.0%
2018	$2.40B	-29.8%
2017	$3.41B	+13.3%
2016	$3.01B	-0.4%
2015	$3.02B	+16.8%
2014	$2.59B	-12.3%
2013	$2.95B	-1.9%
2012	$3.01B	-1.8%
2011	$3.07B	+6.1%
2010	$2.89B	+1,076.8%
2002	$245.54M	-59.6%
1999	$608.00M	+42.4%
1998	$426.90M	-27.7%

Year	Value	Change
1997	$590.30M	+24.4%
1996	$474.66M	-29.4%
1995	$672.50M	+0.7%
1994	$667.98M	+27.3%
1993	$524.63M	-15.8%
1992	$623.29M	-15.7%
1991	$739.57M	+43.6%
1990	$514.85M	+15.1%
1989	$447.28M	+22.3%
1988	$365.59M	+9.5%
1987	$334.00M	+23.1%
1986	$271.22M	+15.5%
1985	$234.86M	+23.8%
1984	$189.65M	+6.1%
1983	$178.78M	+107.3%
1982	$86.25M	-20.2%
1981	$108.06M	+155.8%
1980	$42.25M	-

FAQ

What is the current annual cash & cash equivalents of NVO?: As of today, NVO annual cash & cash equivalents is $4.24B
What is 1-year change in NVO annual cash & cash equivalents?: NVO annual cash & cash equivalents is up +16.05% year-over-year
What is 3-year change in NVO annual cash & cash equivalents?: NVO annual cash & cash equivalents is up +25.31% over the past 3 years
How far is NVO annual cash & cash equivalents from its all-time high?: NVO annual cash & cash equivalents is currently -5.36% below its historical high of $4.48B set on December 31, 2023
How does NVO annual cash & cash equivalents rank versus sector peers?: NVO annual cash & cash equivalents is higher than 97.00% of companies in Healthcare sector
When is NVO next annual earnings release?: As of today, the next annual earnings release for NVO has not been scheduled

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Quarterly Cash & Cash Equivalents

$6.88B$3.55B+106.33%

June 30, 2026

Summary

Current Value: As of today, NVO quarterly cash & cash equivalents is $6.88B, up +106.33% on June 30, 2026
Historical Performance: NVO quarterly cash & cash equivalents is up +130.95% year-over-year, up +28.97% over the past 3 years
All-Time High Comparison: NVO quarterly cash & cash equivalents is currently -38.63% below its historical high of $11.21B set on September 30, 2024
3-Year Low Comparison: NVO quarterly cash & cash equivalents is +410.77% above its 3-year low of $1.35B reached on March 31, 2024
Sector Comparison: NVO quarterly cash & cash equivalents is higher than 98.49% of companies in Healthcare sector

Performance

NVO Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly Cash & Cash Equivalents	Jun 30, 26	$6.88B	+106.3%	+130.9%	+29.0%	+58.5%
Annual Cash & Cash Equivalents	Dec 31, 25	$4.24B	–	+16.1%	+25.3%	+102.2%
Price	Aug 19, 26	$46.68	+5.4%	-14.8%	-49.0%	-11.6%
Quarterly Current Assets	Jun 30, 26	$31.92B	+16.8%	+24.7%	+58.4%	+159.4%
Quarterly Total Liabilities	Jun 30, 26	$57.15B	+4.1%	+15.7%	+105.0%	+287.3%
Quarterly Working Capital	Jun 30, 26	-$4.65B	+37.0%	+34.1%	-66.4%	-770.3%
Quarterly Net Income	Jun 30, 26	$3.27B	-57.1%	-18.9%	+15.1%	+66.2%

Quarterly Cash & Cash Equivalents Highs

NVO Quarterly Cash & Cash Equivalents Highs Comparison
Period	High	Date	Current
1Y	$6.88B	Jun 30, 26	at high
3Y	$11.21B	Sep 30, 24	-38.6%
5Y	$11.21B	Sep 30, 24	-38.6%
All	$11.21B	Sep 30, 24	-38.6%

Quarterly Cash & Cash Equivalents Lows

NVO Quarterly Cash & Cash Equivalents Lows Comparison
Period	Low	Date	Current
1Y	$2.98B	N/A	+130.9%
3Y	$1.35B	Mar 31, 24	+410.8%
5Y	$1.35B	Mar 31, 24	+410.8%
All	$124.70M	Dec 31, 98	+5417.2%

Quarterly Cash & Cash Equivalents History

Month	Value	Change
Jun 2026	$6.88B	+106.3%
Mar 2026	$3.33B	-21.3%
Dec 2025	$4.24B	-17.3%
Sep 2025	$5.13B	+72.2%
Jun 2025	$2.98B	-50.5%
Mar 2025	$6.02B	+64.7%
Dec 2024	$3.65B	-67.4%
Sep 2024	$11.21B	+24.5%
Jun 2024	$9.00B	+568.5%
Mar 2024	$1.35B	-69.9%
Dec 2023	$4.48B	-33.7%
Sep 2023	$6.76B	+26.7%
Jun 2023	$5.33B	+31.7%
Mar 2023	$4.05B	+19.7%
Dec 2022	$3.38B	-31.5%
Sep 2022	$4.94B	+13.2%
Jun 2022	$4.36B	+44.8%
Mar 2022	$3.01B	+12.7%
Dec 2021	$2.67B	-51.5%
Sep 2021	$5.52B	+27.1%
Jun 2021	$4.34B	+258.3%
Mar 2021	$1.21B	-42.2%
Dec 2020	$2.10B	-47.8%
Sep 2020	$4.01B	+7.1%
Jun 2020	$3.75B	+161.1%
Mar 2020	$1.44B	-38.2%
Dec 2019	$2.32B	-15.1%
Sep 2019	$2.74B	+24.2%
Jun 2019	$2.21B	+62.0%
Mar 2019	$1.36B	-43.1%
Dec 2018	$2.40B	-7.6%
Sep 2018	$2.59B	-13.1%
Jun 2018	$2.98B	+41.9%
Mar 2018	$2.10B	-38.4%
Dec 2017	$3.41B	-1.1%
Sep 2017	$3.45B	-2.6%
Jun 2017	$3.54B	+36.3%
Mar 2017	$2.60B	-13.7%
Dec 2016	$3.01B	+16.4%
Sep 2016	$2.59B	+9.5%
Jun 2016	$2.36B	+50.4%
Mar 2016	$1.57B	-48.1%

Month	Value	Change
Dec 2015	$3.02B	+11.7%
Sep 2015	$2.71B	+48.4%
Jun 2015	$1.82B	+70.6%
Mar 2015	$1.07B	-58.7%
Dec 2014	$2.59B	+12.0%
Sep 2014	$2.31B	+86.9%
Jun 2014	$1.24B	+9.7%
Mar 2014	$1.13B	-61.8%
Dec 2013	$2.95B	+11.0%
Sep 2013	$2.66B	-11.6%
Dec 2012	$3.01B	-1.2%
Sep 2012	$3.05B	+43.7%
Jun 2012	$2.12B	-11.6%
Mar 2012	$2.40B	-25.2%
Jun 2011	$3.21B	+10.9%
Dec 2010	$2.89B	+21.4%
Sep 2010	$2.38B	+20.8%
Jun 2010	$1.97B	+6.5%
Mar 2010	$1.85B	+60.5%
Sep 2007	$1.15B	+14.3%
Jun 2007	$1.01B	+16.9%
Mar 2007	$862.51M	+123.6%
Mar 2004	$385.76M	+57.1%
Dec 2002	$245.54M	+25.3%
Dec 2001	$196.03M	+23.3%
Dec 2000	$159.01M	-7.3%
Dec 1999	$171.62M	+37.6%
Dec 1998	$124.70M	-24.3%
Dec 1997	$164.71M	+7.1%
Dec 1996	$153.76M	-71.5%
Dec 1995	$540.42M	-50.8%
Dec 1994	$1.10B	+30.4%
Dec 1993	$842.90M	-9.4%
Dec 1992	$930.22M	-8.9%
Dec 1991	$1.02B	+36.0%
Dec 1990	$750.32M	+68.4%
Dec 1989	$445.58M	+21.6%
Dec 1988	$366.29M	+9.2%
Dec 1987	$335.56M	+23.7%
Dec 1986	$271.32M	+15.6%
Dec 1985	$234.75M	+23.7%
Dec 1984	$189.82M	-

FAQ

What is the current quarterly cash & cash equivalents of NVO?: As of today, NVO quarterly cash & cash equivalents is $6.88B
What is NVO quarterly cash & cash equivalents most recent change?: NVO quarterly cash & cash equivalents was up +106.33% on June 30, 2026
What is 1-year change in NVO quarterly cash & cash equivalents?: NVO quarterly cash & cash equivalents is up +130.95% year-over-year
How far is NVO quarterly cash & cash equivalents from its all-time high?: NVO quarterly cash & cash equivalents is currently -38.63% below its historical high of $11.21B set on September 30, 2024
How does NVO quarterly cash & cash equivalents rank versus sector peers?: NVO quarterly cash & cash equivalents is higher than 98.49% of companies in Healthcare sector
When is NVO next earnings release?: The next earnings release for NVO is on November 4, 2026

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

NVO Official Website www.novonordisk.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm
NVO Profile on Yahoo Finance finance.yahoo.com/quote/NVO
NVO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvo